Overview

A Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings in Postmenopausal Women

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
A study to assess the pharmacokinetics of 2 progesterone vaginal rings in postmenopausal women
Phase:
Phase 1
Details
Lead Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Teva Branded Pharmaceutical Products, R&D Inc.
Treatments:
Progesterone